Warby Parker Inc. (WRBY) — ESG & Values Scores

Environment story

Warby Parker demonstrates moderate environmental performance with nascent disclosure practices. The company has not published detailed Scope 1, 2, or 3 emissions data in the 10-K filing, nor articulated a specific net-zero target year. Risk factors acknowledge ESG scrutiny and the potential for reputational harm if sustainability goals are not achieved, but concrete decarbonization infrastructure investments are not quantified. The company's status as a certified B Corporation suggests values-alignment, yet environmental reporting remains underdeveloped relative to peer standards. Tariff pressures and supply-chain complexity are noted risks; no evidence of greenwashing via offsets was identified, but absence of emissions disclosure prevents validation of operational decarbonization.

Criticisms on file

Undisclosed Scope 1, 2, and 3 emissions; no net-zero target articulated
Source: WRBY 10-K 2025 (Item 1A Risk Factors, Environmental Risks section) — company acknowledges heightened ESG scrutiny but does not disclose emissions baseline or reduction targets.
Tariff-driven cost volatility affecting supply chain carbon footprint; no mitigation pathway disclosed
Source: WRBY 10-K 2025 (MD&A, Overall Economic Environment section) — tariffs on China imports mentioned; company states cost-offset strategies (supplier diversification, price increases) but does not quantify carbon impact of logistics or manufacturing relocation.
ESG disclosure expectations vs. realization risk
Source: WRBY 10-K 2025 (Item 1A Risk Factors, ESG section) — company acknowledges risk that failure to realize aspirational ESG goals could harm reputation and ratings.

Disclosed initiatives

B Corporation & Public Benefit Corporation Status

Company maintains certified B Corporation status and operates as a public benefit corporation focused on positive stakeholder impact; Buy a Pair, Give a Pair program has distributed glasses to 20+ million people across 80+ countries.

Values-alignment signal; does not directly address carbon emissions or operational decarbonization.
Supply Chain Diversification

Company has initiated efforts to diversify supplier base outside China to mitigate tariff exposure; expanding domestic optical laboratory network and international frame manufacturing partnerships.

Reduces reliance on single-source supply chains; potential for reduced transportation emissions if localized production increases, but not quantified.
Vertical Integration & Optical Laboratory Network

Company operates owned optical laboratories and invests in supply chain infrastructure to reduce friction in production and logistics.

May yield efficiency gains and reduced freight; no explicit carbon reduction claims or metrics disclosed.

Social story

Warby Parker exhibits above-average social performance characterized by mission-driven culture, pro-labor neutrality stance, and strategic diversity investments, but lacks detailed public disclosure of workforce representation metrics and CEO-to-median-worker pay ratios. The company emphasizes company culture as a competitive advantage and claims focus on recruiting and retaining motivated employees. No active union-suppression litigation or major strikes are disclosed in the 10-K; labor relations appear stable. Diversity is highlighted as a value but quantitative leadership/board diversity percentages are not disclosed in the filing. Supply-chain labor audits are not detailed; the company sources components internationally (predominantly China) with optical laboratory operations in China, presenting moderate human-rights oversight risk. The public benefit corporation mandate and B Corp certification reinforce social values but do not substitute for transparent quantitative reporting.

Criticisms on file

Undisclosed CEO-to-median-worker pay ratio and workforce diversity percentages
Source: WRBY 10-K 2025 — filing does not include EEO-1 disclosure, pay equity statements, or CEO pay ratio; no formal diversity metrics disclosed.
International optical laboratory and China supply-chain labor oversight
Source: WRBY 10-K 2025 (Item 1A Risk Factors, Supply Chain section) — company sources all components and operates optical laboratories predominantly in China; no documented labor audits or supply-chain human-rights certification disclosed.
Optometrist/healthcare professional recruitment and retention risk
Source: WRBY 10-K 2025 (Item 1A Risk Factors, Optometrist Recruitment section) — company acknowledges competitive pressure in hiring eye-care professionals and potential pressure on margins from increased compensation; no union agreements or professional safeguards disclosed.

Disclosed initiatives

Buy a Pair, Give a Pair Program

Social enterprise model: for every pair of glasses sold, company donates glasses to people in need; 20+ million pairs distributed across 80+ countries and multiple US regions.

Significant social impact measured in pairs distributed; demonstrates commitment to access and equity; does not directly address workforce social metrics.
Company Culture & Employee Engagement

Leadership explicitly identifies company culture (fun, creativity, doing good) as core to competitive advantage and employee retention; culture positioned as mechanism for attracting and retaining 'highly engaged, motivated team members' aligned with mission.

Positive signal for employee satisfaction and retention, though no quantitative turnover or engagement scores disclosed.
Public Benefit Corporation Structure

Company operates under public benefit corporation legal framework with explicit commitment to positive impact across all stakeholder groups (employees, customers, communities, environment).

Structural accountability for social performance; may support diversity and labor practices, but no specific programs or metrics disclosed in 10-K.
Telehealth & Accessibility Initiatives

Virtual Vision Test app (telehealth) and Virtual Try-On tool enable remote access to eye exams and product discovery; expanded vision care through partnership with optometrists and independent professional corporations.

Expands access to vision care services; addresses healthcare equity dimension; service scale not quantified in 10-K.

Governance story

Warby Parker demonstrates moderate-to-strong governance with single-class share structure (positive), stable co-founder/co-CEO leadership, and absence of major antitrust or regulatory enforcement actions. Board independence percentage is not disclosed in the 10-K, preventing full assessment against the 75% threshold. The company operates as a public benefit corporation, adding governance accountability layer. Lobbying expenditure is not disclosed; no evidence of anti-climate or anti-consumer-protection lobbying is apparent. The company faced a minor HIPAA violation (2018 credential-stuffing incident resolved via $0 civil penalty in December 2024 after investigation closure in February 2025), indicating compliance responsiveness. Significant cybersecurity, data-privacy, and AI-related regulatory risks are acknowledged but not quantified as active enforcement actions. No dual-class voting, supermajority founder control, or antitrust litigation is disclosed. Overall governance posture appears compliant with public company standards.

Criticisms on file

2018 credential-stuffing security incident and HIPAA violation investigation
Source: WRBY 10-K 2025 (Item 1A Risk Factors, HIPAA/Privacy section) — company disclosed receipt of OCR investigation notice following 2018 credential-stuffing attack; paid civil monetary penalty in December 2024; investigation closed February 2025. Company proactively cooperated with OCR.
Board independence percentage not disclosed
Source: WRBY 10-K 2025 — filing does not include board composition or independence metrics; prevents verification against 75% threshold.
Lobbying expenditure and political engagement not disclosed
Source: WRBY 10-K 2025 — no lobbying spend, PAC contributions, or political engagement disclosed; unable to assess alignment with climate or consumer-protection regulation.
AI governance and responsible-deployment risk acknowledgment
Source: WRBY 10-K 2025 (Item 1A Risk Factors, AI section) — company acknowledges risks of bias, discrimination, privacy violations, and security threats related to AI use in operations and product development (e.g., AI-powered smart glasses partnership with Google); no explicit governance framework or ethical-review process disclosed.

Disclosed initiatives

Public Benefit Corporation Governance

Company operates under Delaware public benefit corporation statute with explicit legal duty to balance shareholder returns with positive impact on stakeholders (employees, customers, communities, environment).

Structural governance accountability for ESG performance; no quantitative impact metrics disclosed in 10-K.
Data Security & Compliance Program

Company maintains cyber insurance, cybersecurity controls, HIPAA compliance infrastructure, and vendor-risk management; undertaking multi-year IT/ERP system upgrade to support business growth and security posture.

Proactive compliance stance; 2018 credential-stuffing incident was detected and reported, triggering investigation and resolution; ongoing system enhancements reduce future breach risk.
Privacy & GDPR Readiness

Company acknowledges GDPR compliance obligations and PIPEDA/CASL requirements for Canadian operations; implements privacy policies and data-handling standards.

Supports operational readiness for international expansion; no violations disclosed.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of Warby Parker Inc.. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open Warby Parker Inc. in the app for interactive charts and portfolio building.

More in Healthcare

Eli Lilly and Company (LLY) Johnson & Johnson (JNJ) AbbVie Inc. (ABBV) UnitedHealth Group Incorporated (UNH) Merck & Co., Inc. (MRK) Thermo Fisher Scientific Inc. (TMO)